Sign inJoin waitlistJoin the waitlist

Thomas Habermann

Professor of Medicine · Mayo Clinic College of Medicine and Science

Credentials: · · · ·

History

Mayo Clinic College of Medicine and Science
Present

Hematology
1982–1983
Internal Medicine
1979–1982
Creighton University School of Medicine
1975–1979

Research

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Nature Medicine · 2018 · 1,629 citations
Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
Journal of Clinical Oncology · 2006 · First of 11 authors · Corresponding · 1,133 citations
Association of perceived medical errors with resident distress and empathy: a prospective longitudinal study
JAMA · 2006 · 1,039 citations

Thomas Witzig
198 papers · 2 as a fellow
Stephen Ansell
188 papers
GN
Grzegorz Nowakowski
130 papers
BL
Brian Link
105 papers
Carrie Thompson
88 papers
DI
David Inwards
87 papers · 2 as a fellow
Patrick Johnston
77 papers
Ivana Micallef
73 papers
WM
William Macon
67 papers
Andrew Feldman
64 papers
Yucai Wang
57 papers · 5 as a fellow
Luis Porrata
53 papers

Grants

Lymphoma Specialized Program of Research Excellence (SPORE) in Human Cancer
National Cancer Institute · P50
Project lead · $3.2M · University of Iowa
2002–2017
Eastern Cooperative Oncology Group
National Cancer Institute · U10
Contact PI · $4.5M · Mayo Clinic Rochester
1978–2016

Clinical trials

Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, LS1681 Trial
Principal investigator · Completed · Phase 1
Mayo Clinic
2019–2023